Phase III Trial of Gemcitabine plus Docetaxel (GD) Compared to Capecitabine plus Docetaxel (CD) with Planned Crossover to the Alternate Single Agent in.
CAELYX CLINICAL TRIALS Metastatic Breast Cancer (MBC)
